Onyx Biotec Releases Corrigendum Regarding Open Offer Shareholding Details
Onyx Biotec Ltd 路 Others (Uncategorized) 路 18 Nov 2026, 10:58 pm
Onyx Biotec Releases Corrigendum Regarding Open Offer Shareholding Details VC Corporate Advisors issued a corrigendum dated 7th Nov'26 to the Letter of Offer regarding the open offer for acquiring up to 47,14,372 equity shares (26.00% of voting share capital) of Onyx Biotec Ltd by Kunal Bhardwaj, Gautam Bhardwaj, Kanhaiya Bhardwaj, and Kapil Bhardwaj. The corrigendum rectifies promoter shareholding records following an NSE observation: Ms. Riya Chadha was erroneously listed under public shareholding holding 4,000 equity shares (0.02%), whereas she belongs to the promoter category. Consequently, aggregate promoter holding stands at 75,65,200 shares (41.72%).
Original exchange filing (PDF)
More announcements from Onyx Biotec Ltd
- Onyx Biotec Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 路 14 Nov 2026
- Onyx Biotec Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- VC Corporate Advisors Private Limited has Submitted to the Exchange a copy of corrigendum to the letter of offer for the attention to the public shareholders of the Onyx Biotec Limited. 路 12 Nov 2026
- Onyx Biotec Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 14 Nov 2026
- VC Corporate Advisors Private Limited has Submitted to the Exchange a copy of offer opening public announcement cum corrigendum to the detailed public statement to the public shareholders of the聽Onyx Biotec Limited (Target Company). 路 14 Oct 2026
- Onyx Biotec Limited has informed regarding Submission of the Non-Applicability of the provisions relating to Corporate Governance as specified in the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. 路 14 Oct 2026
- Onyx Biotec Limited has Submitted to the Exchange a newspaper copy of the Recommendation of the Independent Director Committee ("IDC") of the company in relation to the Open Offer made by Mr. Kunal Bhardwaj ( Acquirer 1 ), Mr. Gautam Bhardwaj ( Acquirer 2 ), Mr. Kanhaiya Bhardwaj ( Acquirer 3 ) and Mr. Kapil Bhardwaj ( Acquirer 4 ) (hereinafter collectively referred to as the Acquirers ) to the public shareholders of the company under Regulation 26(7) of SEBI (SAST) Regulations, 2011 and subseq 路 08 Oct 2026
